IPP Bureau
Alembic Pharmaceuticals appoints Manish Kejriwal as Independent Director
By IPP Bureau - April 02, 2024
Apotex to acquire Canadian Searchlight Pharma
By IPP Bureau - April 02, 2024
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Vivity reaches 1 million milestone
By IPP Bureau - April 02, 2024
Vivity is the first and only wavefront-shaping IOL with Alcon’s proprietary X-WAVE Technology
Viatris launches RYZUMVl 0.75% in US
By IPP Bureau - April 02, 2024
The average time of dilation lasts three to eight hours
AstraZeneca and Daiichi Sankyo’s BLA for Dato-DXd accepted in the US for treatment of breast cancer
By IPP Bureau - April 02, 2024
Application based on results from the TROPION-Breast01 Phase III trial
MTD acquires Ypsomed's pen needle and BGM businesses
By IPP Bureau - April 01, 2024
This acquisition enables MTD to open new, strategic markets
Bio-Techne partners with Nikon Instruments for innovative spatial biology services
By IPP Bureau - April 01, 2024
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
FDA Granted ODD to Utidelone Injectable from Biostar Pharma for treatment of breast cancer brain metastasis
By IPP Bureau - April 01, 2024
Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
Krazati monotherapy shows significant survival benefit in KRAS G12C-mutated NSCLC Phase III Krystal -12 data
By IPP Bureau - April 01, 2024
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
Biocon's European partner Zentiva receives approval from UK MHRA for Liraglutide
By IPP Bureau - April 01, 2024
The company had earlier announced about the approval received from the MHRA for Liraglutide
Venus Remedies receives Rs. 2.50 crore under PLI scheme
By IPP Bureau - April 01, 2024
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
Concept Medical receives USFDA approval for sirolimus drug-coated balloon
By IPP Bureau - April 01, 2024
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
Mankind Pharma introduces 'Digital Smart Class' initiative across rural India
By IPP Bureau - March 30, 2024
Establishment of 220 smart classrooms across Uttar Pradesh, Uttarakhand, and Himachal Pradesh
Aragen operationalizes first phase of its US$ 30 million Biologics manufacturing facility in India
By IPP Bureau - March 30, 2024
Executes the first project for developing and manufacturing a novel anticancer mAb
Truqap plus Faslodex approved in Japan for patients with advanced HR-positive breast cancer
By IPP Bureau - March 30, 2024
First and only AKT inhibitor approved in Japan for breast cancer patients with specific biomarker alterations
